Jyri Lommi

Jyri Lommi

Auto-generated profile, based on publicly available information

Jyri Lommi

Department of Cardiology, Heart and Lung Center, Helsinki University Hospital and University of Helsinki , Helsinki

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2021 in European Heart Journal - Quality of Care and Clinical Outcomes
Verified
Journal Article
Open access
PDF file
HLHanna-Riikka Lehto
Hanna-Riikka Lehto
KWKlas Winell
Klas Winell
APArto Pietilä
Arto Pietilä
TNTeemu J Niiranen
Teemu J Niiranen
JLJyri Lommi
Jyri Lommi
VSVeikko Salomaa
Veikko Salomaa
Aims: To assess the prognosis of patients with coronary heart disease (CHD) after first myocardial revascularisation procedure in real-world practice and to compare the differences in outcomes of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) among diabetic and non-diabetic patients.Methods and results: A database was compiled from the national hospital discharge register to collect data on all cardiac revascularisations performed in Finland in 2000–2015. The outcomes (all-cause deaths, cardiovascular (CV) deaths, major CV events and need for repeat revascularisation) after the first revascularisation were identified from the national registers at 28 day, 1 year, and 3 year time points.A total of 139 242 first-time revascularisations (89 493 PCI and 49 749 CABG) were performed during the study period. Of all the revascularised patients, 24% had diabetes, and 76% were non-diabetic patients. At day 28, the risk of fatal outcomes was lower after PCI than after CABG among non-diabetic patients, whereas no difference was seen among diabetic patients. In long-term follow-up the situation was reversed with PCI showing higher risk compared with CABG for most of the outcomes. In particular, at 3 year follow-up the risk of all-cause deaths was elevated among diabetic patients [HR 1.30 (95% CI 1.22–1.38) comparing PCI with CABG] more than among non-diabetic patients [HR 1.09 (1.04–1.15)]. The same was true for CV deaths [HR 1.29 (1.20–1.38) among diabetic patients, and HR 1.03 (0.98–1.08) among non-diabetic patients].Conclusion: Although PCI was associated with better 28 day prognosis, CABG seemed to produce better long-term prognosis especially among diabetic patients.

26 March 2026 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
MTMarko Taipale
Marko Taipale
MPMarkku Pentikäinen
Markku Pentikäinen
LMLaura Martelius
Laura Martelius
AMAino Mutka
Aino Mutka
SKSoili Kytölä
Soili Kytölä
TOTiina Ojala
Tiina Ojala

1 January 2026 in European Heart Journal - Imaging Methods and Practice
Verified
Journal Article
Open access
RHReetta Hälvä
Reetta Hälvä
SVSatu Vaara
Satu Vaara
SSSuvi Syväranta
Suvi Syväranta
MHMiia Holmström
Miia Holmström
JFJohanna Federico
Johanna Federico
VUValtteri Uusitalo
Valtteri Uusitalo
Aims: The aim of this study was to determine the impact of obstructive coronary artery disease (CAD) and diffuse atherosclerosis on left ventricular systolic function, measured as global longitudinal strain (GLS) by cardiac magnetic resonance (CMR) feature tracking, in patients with severe aortic stenosis (AS). Methods and results: In this single-centre prospective cohort study, patients with severe AS and transcatheter aortic valve implantation (TAVI) between October 2018 and February 2022 were referred for transthoracic echocardiography, CMR, and TAVI computed tomography. Invasive coronary angiography was performed before TAVI. Ninety-four patients (80 ± 7 years) were included. The prevalence of obstructive CAD was 20 (21%) patients. The mean GLS in patients with severe AS was −24.0 ± 6.1%, and the median coronary calcium score was 802 (interquartile range 302–2130). GLS was not reduced in patients with obstructive CAD compared to other patients (23.7 ± 5.9% vs. 24.1 ± 6.2%, P = 0.83). A high coronary calcium score was not associated with GLS. Indexed left ventricular mass was independently related to GLS. Patients with an ischaemic scar on CMR had lower GLS (20.3 ± 5.1% vs. 24.6 ± 6.1%, P = 0.02). Conclusion: GLS correlated with left ventricular mass and the presence of ischaemic scar, suggesting that intrinsic myocardial disease, rather than concomitant CAD alone, accounts for reduced GLS in this population.